BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 10385926)

  • 1. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carbamazepine on the pharmacokinetics of promazine.
    Syrek M; Wójcikowski J; Daniel W
    Pol J Pharmacol; 1996; 48(6):601-8. PubMed ID: 9112700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
    Daniel WA; Syrek M; Haduch A
    Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of amitriptyline and imipramine on the pharmacokinetics and metabolism of perazine in rats.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2000 Dec; 52(12):1473-81. PubMed ID: 11197075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA; Haduch A; Wójcikowski J
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine.
    Wójcikowski J; Maurel P; Daniel WA
    Drug Metab Dispos; 2006 Mar; 34(3):471-6. PubMed ID: 16272405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of cytochrome P-450 isoenzymes to the metabolism of phenothiazine neuroleptics.
    Daniel WA; Syrek M; Haduch A
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):371-7. PubMed ID: 12208554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA; Syrek M; Ryłko Z; Kot M
    Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants.
    Syrek M; Wójcikowski J; Daniel WA
    Pol J Pharmacol; 1997; 49(6):453-62. PubMed ID: 9566049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
    Daniel WA; Kot M; Wójcikowski J
    Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction between imipramine and antidepressant neuroleptics in rats.
    Daniel W
    Pol J Pharmacol Pharm; 1991; 43(3):197-206. PubMed ID: 1683700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes.
    Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
    Eur Neuropsychopharmacol; 2004 May; 14(3):199-208. PubMed ID: 15056479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interaction between carbamazepine and neuroleptics after combined prolonged treatment in rats.
    Daniel W; Janczar L; Danek L; Legrum W; Netter KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):598-605. PubMed ID: 1356236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution interactions between perazine and antidepressant drugs. In vivo studies.
    Wójcikowski J; Daniel WA
    Pol J Pharmacol; 2000; 52(6):449-57. PubMed ID: 11334238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between neuroleptics and CYP2C6 in rat liver--in vitro and ex vivo study.
    Haduch A; Ogórka T; Boksa J; Daniel WA
    Pharmacol Rep; 2005; 57(6):872-7. PubMed ID: 16382211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Main contribution of the cytochrome P450 isoenzyme 1A2 (CYP1A2) to N-demethylation and 5-sulfoxidation of the phenothiazine neuroleptic chlorpromazine in human liver--A comparison with other phenothiazines.
    Wójcikowski J; Boksa J; Daniel WA
    Biochem Pharmacol; 2010 Oct; 80(8):1252-9. PubMed ID: 20615392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine.
    Daniel W; Syrek M; Janczar L; Boksa J
    Pol J Pharmacol; 1995; 47(2):127-36. PubMed ID: 8688885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.